PACAP as a neuronal cell death in hibiting function
PACAP 作为抑制功能的神经元细胞死亡
基本信息
- 批准号:08458249
- 负责人:
- 金额:$ 4.29万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We found that infusion of a very low concentration of PACAP (Pituitary Adenylate Cyclase Activating Polypeptide) in the cerebral ventrclle as well as in the femoral vein preventd delayd neyronal cell death (apoptosis) in rat hippocampal CA1 region. However, the molecular mechanisms underlying the anti-apoptotic effect of PACAP remain to be determined. The aim of this study was to clarify functional significance of PACAP in preventing neuronal cell death in rat hippocampus. We demonstra ted that the activities of members of the mitogen-activated protein (MAP) kinase family, including extracellular siganl-regulated kinase (ERK), Jun N-terminal kinase (JNK) /stress-activated protein kinase (SAPK), and p38 were increased in the hippocampus. The is chemic stress had a potent in fluence on the MAP kinase family, especially on JNK/SAPK.PACAP inhibited the activation of JNK/SAPK after ischemic stress. Secretion of interleukin-6 (IL-6) into the cerebrospinal fluid was intensly stimulated after PACAP infucion. IL-6 inhibited the activation of JNK/SAPK,while it activated ERK.These observations strongly suggest that PACAP and IL-6 act to inhibit the JNK/SAPK sigualing pathway, thereby protecting neurons against apoptosis. The present study suggest that a low concentration of PACAP in the brain which prevents the ischemic death of CA1 regions can be reached by the systemic administration of a low dose of the peptide. The results are in contrast to those with other neuroprotective compouds and should be clinically very important.
我们发现,在脑室和股静脉中输注极低浓度的 PACAP(垂体腺苷酸环化酶激活多肽)可以防止大鼠海马 CA1 区域的延迟性神经元细胞死亡(细胞凋亡)。然而,PACAP 抗凋亡作用的分子机制仍有待确定。本研究的目的是阐明 PACAP 在预防大鼠海马神经元细胞死亡中的功能意义。我们证明,丝裂原激活蛋白 (MAP) 激酶家族成员的活性在海马中增加,包括细胞外信号调节激酶 (ERK)、Jun N 末端激酶 (JNK)/应激激活蛋白激酶 (SAPK) 和 p38。缺血应激对MAP激酶家族尤其是JNK/SAPK有很强的影响。PACAP抑制缺血应激后JNK/SAPK的激活。 PACAP 输注后,白细胞介素 6 (IL-6) 分泌到脑脊液中受到强烈刺激。 IL-6抑制JNK/SAPK的激活,同时激活ERK。这些观察结果强烈表明PACAP和IL-6可以抑制JNK/SAPK信号通路,从而保护神经元免于凋亡。目前的研究表明,通过全身施用低剂量的肽,可以达到大脑中低浓度的 PACAP,从而防止 CA1 区域的缺血性死亡。该结果与其他神经保护化合物的结果相反,在临床上应该非常重要。
项目成果
期刊论文数量(43)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shioda S,Yada T,Nakajo S,Nakaya K,Nakai Y,Arimura A.: "Pituitay adenylate cyclase-activating polypeptide (PACAP) : a novel regulator of vasopressin-containig neurons." Brain Research. 765. 81-90 (1997)
Shioda S,Yada T,Nakajo S,Nakaya K,Nakai Y,Arimura A.:“Pituitay 腺苷酸环化酶激活多肽(PACAP):含有加压素神经元的新型调节剂。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shioda,S.: "PACAP and its type I receptors in the rat hypothalamus : Neuroendocrine interaction." Ann NY Acad Sci. 805. 670-676 (1996)
Shioda,S.:“大鼠下丘脑中的 PACAP 及其 I 型受体:神经内分泌相互作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shioda,S.: "Pituitary adenylate cyclase-activating polypeptide : a key player in male reproduction?" Amalus of Endocrinology. 57. 57 (1996)
Shioda,S.:“垂体腺苷酸环化酶激活多肽:男性生殖的关键角色?”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shioda S,Nakai Y,Nakajo S,Nakaya K,Arimura A.: "PACAP and its type I receptors in the rat hypothalamus : neuroendocrine in teraction." Ann NY Acad Sci. 805. 670-676 (1996)
Shioda S、Nakai Y、Nakajo S、Nakaya K、Arimura A.:“大鼠下丘脑中的 PACAP 及其 I 型受体:神经内分泌的相互作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Li M,Shioda S,Somogyvari-Vigh, Onda H,Arimura A.: "Specific antibody recognition of rat pituitary abenylate cyclase activating polypeptide receptors." Endocrine. 7. 183-190 (1997)
Li M、Shioda S、Somogyvari-Vigh、Onda H、Arimura A.:“大鼠垂体苯甲酸环化酶激活多肽受体的特异性抗体识别。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIODA Seiji其他文献
SHIODA Seiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIODA Seiji', 18)}}的其他基金
A new strategy to conquer obesity by use of a newly discovered neuropeptide GALP
利用新发现的神经肽 GALP 征服肥胖的新策略
- 批准号:
21659059 - 财政年份:2009
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Demonstration of PACAP on protection of delayed neuronal cell death and its molecular mechanism of neuroregeneration.
PACAP对迟发性神经细胞死亡的保护作用及其神经再生的分子机制的论证。
- 批准号:
20390461 - 财政年份:2008
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Prevention of delayed neuronal cell death by PACAP and its molecular mechanism
PACAP预防神经细胞迟发性死亡及其分子机制
- 批准号:
14380354 - 财政年份:2002
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional significance of tumor necrosis factor alpha in inducing retinal ganglion cell death by using gene targeting method
肿瘤坏死因子α基因靶向诱导视网膜神经节细胞死亡的功能意义
- 批准号:
11671758 - 财政年份:1999
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional significance of PACAP receptors in regulating secretion and synthesis of vasopressi
PACAP受体在调节加压素分泌和合成中的功能意义
- 批准号:
10680708 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional significance of PACAP in inhibiting neuronal cell death by using gene targeting method
PACAP基因打靶抑制神经细胞死亡的功能意义
- 批准号:
09558098 - 财政年份:1997
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
GPR4 in blood brain barrier dysfunction in brain ischemia
GPR4在脑缺血血脑屏障功能障碍中的作用
- 批准号:
10711110 - 财政年份:2022
- 资助金额:
$ 4.29万 - 项目类别:
Change in NSF ATPase activity Leads to Brain Ischemia Reperfusion Injury
NSF ATP酶活性变化导致脑缺血再灌注损伤
- 批准号:
10748602 - 财政年份:2022
- 资助金额:
$ 4.29万 - 项目类别:
GPR4 in blood brain barrier dysfunction in brain ischemia
GPR4在脑缺血血脑屏障功能障碍中的作用
- 批准号:
10522141 - 财政年份:2022
- 资助金额:
$ 4.29万 - 项目类别:
Novel anti-NPC aggregation strategy against brain ischemia-reperfusion injury
抗脑缺血再灌注损伤的新型抗NPC聚集策略
- 批准号:
10747258 - 财政年份:2022
- 资助金额:
$ 4.29万 - 项目类别:
Metabolic origin of oxidative stress injury in brain ischemia/reperfusion
脑缺血/再灌注氧化应激损伤的代谢起源
- 批准号:
10354477 - 财政年份:2022
- 资助金额:
$ 4.29万 - 项目类别:
GPR4 in blood brain barrier dysfunction in brain ischemia
GPR4在脑缺血血脑屏障功能障碍中的作用
- 批准号:
10652655 - 财政年份:2022
- 资助金额:
$ 4.29万 - 项目类别:
Metabolic Origin of Oxidative Stress Injury in Brain Ischemia/Reperfusion
脑缺血/再灌注氧化应激损伤的代谢起源
- 批准号:
10592282 - 财政年份:2022
- 资助金额:
$ 4.29万 - 项目类别:
Association of brain temperature increase and cerebrospinal fluid dynamics in chronic brain ischemia due to main trunk occlusion of cerebral arteries
脑动脉主干闭塞所致慢性脑缺血脑温度升高与脑脊液动力学的关系
- 批准号:
21K09108 - 财政年份:2021
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Neuroprotective role of OGR1 in brain ischemia
OGR1在脑缺血中的神经保护作用
- 批准号:
10505248 - 财政年份:2021
- 资助金额:
$ 4.29万 - 项目类别:
Novel Ultrasound Indices of Intracranial Pressure and Brain Ischemia in Neonatal Hydrocephalus
新生儿脑积水颅内压和脑缺血的新型超声指标
- 批准号:
10455577 - 财政年份:2020
- 资助金额:
$ 4.29万 - 项目类别: